Genetic Testing for Cancer and Blood Disorders

The lab analyst performs a genomic sequence analysis panel to evaluate the patient specimen, such as tumor tissue or bone marrow, for DNA and possibly RNA alterations in 51 or more genes known to relate to solid organ cancers or to blood or lymph (hematolymphoid) disorders or cancers. Choose a location to see hospital-reported price summaries. This page does not show national, sample, or aggregate pricing.